TNF and Alzheimer disease: By employing both in vitro (HaCaT cells stimulated with TNF-α) and in vivo (DNCB-induced AD model in BALB/c mice) approaches, the findings provide robust evidence of CPKE’s efficacy across complementary experimental systems.